The role of macrophage migration inhibitory factor in maintaining the immune privilege at the fetal–maternal interface

  • Paola Viganò
  • Marcella Cintorino
  • Frederick Schatz
  • Charles J. Lockwood
  • Felice Arcuri
Review

Abstract

Macrophage migration inhibitory factor (MIF) is a pivotal regulator of the innate and adaptive immunity affecting the response and behavior of macrophages and lymphocytes. MIF is also implicated in other fundamental cellular processes including angiogenesis and cell proliferation. Several studies examined the expression of MIF in reproductive organs and tissues and its involvement in different aspects of human and animal reproduction. The goal of this review was to summarize these findings and discuss, in particular, the role of MIF in the maintenance of the immune privilege at the human fetal–maternal interface.

Keywords

MIF Pregnancy Immunosuppression Uterine NK cells Decidual macrophages 

Notes

Acknowledgments

Studies in the authors’ laboratories were supported by grants from the Italian Ministry of Education and Scientific Research, the University of Siena, and by the National Institutes of Health 2 R01HD 33937-05 and 1 R01 HL070004-03. The authors would like to thank Dr. Paolo Toti, Lynn Buchwalder,and Antonietta Carducci for their invaluable help.

References

  1. 1.
    George M, Vaughan JH (1962) In vitro cell migration as a model for delayed hypersensitivity. Proc Soc Exp Biol Med 111:514–521PubMedGoogle Scholar
  2. 2.
    Bloom BR, Bennett B (1966) Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153:80–82PubMedGoogle Scholar
  3. 3.
    David JR (1966) Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell–ntigen interaction. Proc Natl Acad Sci USA 56:72–77PubMedGoogle Scholar
  4. 4.
    Churchill WH Jr, Piessens WF, Sulis CA, David JR (1975) Macrophages activated as suspension cultures with lymphocyte mediators devoid of antigen become cytotoxic for tumor cells. J Immunol 115:781–786PubMedGoogle Scholar
  5. 5.
    Nathan CF, Remold HG, David JR (1973) Characterization of a lymphocyte factor which alters macrophage functions. J Exp Med 137:275–290PubMedGoogle Scholar
  6. 6.
    Paralkar V, Wistow G (1994) Cloning the human gene for macrophage migration inhibitory factor (MIF). Genomics 19:48–51PubMedGoogle Scholar
  7. 7.
    Budarf M, McDonald T, Sellinger B, Kozak C, Graham C, Wistow G (1997) Localization of the human gene for macrophage migration inhibitory factor (MIF) to chromosome 22q11.2. Genomics 39:235–236PubMedGoogle Scholar
  8. 8.
    Bozza M, Kolakowski LF Jr, Jenkins NA, Gilbert DJ, Copeland NG, David JR, Gerard C (1995) Structural characterization and chromosomal location of the mouse macrophage migration inhibitory factor gene and pseudogenes. Genomics 27:412–419PubMedGoogle Scholar
  9. 9.
    Mitchell R, Bacher M, Bernhagen J, Pushkarskaya T, Seldin MF, Bucala R (1995) Cloning and characterization of the gene for mouse macrophage migration inhibitory factor (MIF). J Immunol 154:3863–3870PubMedGoogle Scholar
  10. 10.
    Calandra T, Roger T (2003) Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3:791–800PubMedGoogle Scholar
  11. 11.
    Magi B, Bini L, Liberatori S, Marzocchi B, Raggiaschi R, Arcuri F, Tripodi SA, Cintorino M, Tosi P, Pallini V (1998) Charge heterogeneity of macrophage migration inhibitory factor (MIF) in human liver and breast tissue. Electrophoresis 19:2010–2013PubMedGoogle Scholar
  12. 12.
    Suzuki M, Sugimoto H, Nakagawa A, Tanaka I, Nishihira J, Sakai M (1996) Crystal structure of the macrophage migration inhibitory factor from rat liver. Nat Struct Biol 3:259–266PubMedGoogle Scholar
  13. 13.
    Sun HW, Bernhagen J, Bucala R, Lolis E (1996) Crystal structure at 2.6-A resolution of human macrophage migration inhibitory factor. Proc Natl Acad Sci USA 93:5191–5196PubMedGoogle Scholar
  14. 14.
    Blocki FA, Schlievert PM, Wackett LP (1992) Rat liver protein linking chemical and immunological detoxification systems. Nature 360:269–270PubMedGoogle Scholar
  15. 15.
    Nishihira J, Kuriyama T, Nishino H, Ishibashi T, Sakai M, Nishi S (1993) Purification and characterization of human macrophage migration inhibitory factor: evidence for specific binding to glutathione and formation of subunit structure. Biochem Mol Biol Int 31:841–850PubMedGoogle Scholar
  16. 16.
    Sun HW, Swope M, Cinquina C, Bedarkar S, Bernhagen J, Bucala R, Lolis E (1996) The subunit structure of human macrophage migration inhibitory factor: evidence for a trimer. Protein Eng 9:631–635PubMedGoogle Scholar
  17. 17.
    Mischke R, Kleemann R, Brunner H, Bernhagen J (1998) Cross-linking and mutational analysis of the oligomerization state of the cytokine macrophage migration inhibitory factor (MIF). FEBS Lett 427:85–90PubMedGoogle Scholar
  18. 18.
    Philo JS, Yang TH, LaBarre M (2004) Re-examining the oligomerization state of macrophage migration inhibitory factor (MIF) in solution. Biophys Chem 108:77–87PubMedGoogle Scholar
  19. 19.
    Leng L, Metz CN, Fang Y, Xu J, Donnelly S, Baugh J, Delohery T, Chen Y, Mitchell RA, Bucala R (2003) MIF signal transduction initiated by binding to CD74. J Exp Med 197:1467–1476PubMedGoogle Scholar
  20. 20.
    Beswick EJ, Pinchuk IV, Suarez G, Sierra JC, Reyes VE (2006) Helicobacter pylori CagA-dependent macrophage migration inhibitory factor produced by gastric epithelial cells binds to CD74 and stimulates procarcinogenic events. J Immunol 176:6794–6801PubMedGoogle Scholar
  21. 21.
    Meyer-Siegler KL, Iczkowski KA, Leng L, Bucala R, Vera PL (2006) Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells. J Immunol 177:8730–8739PubMedGoogle Scholar
  22. 22.
    Shi X, Leng L, Wang T, Wang W, Du X, Li J, McDonald C, Chen Z, Murphy JW, Lolis E, Noble P, Knudson W, Bucala R (2006) CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 25:595–606PubMedGoogle Scholar
  23. 23.
    Bozza M, Satoskar AR, Lin G, Lu B, Humbles AA, Gerard C, David JR (1999) Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med 189:341–346PubMedGoogle Scholar
  24. 24.
    Bernhagen J, Bacher M, Calandra T, Metz CN, Doty SB, Donnelly T, Bucala R (1996) An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med 183:277–282PubMedGoogle Scholar
  25. 25.
    Leech M, Metz C, Hall P, Hutchinson P, Gianis K, Smith M, Weedon H, Holdsworth SR, Bucala R, Morand EF (1999) Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum 42:1601–1608PubMedGoogle Scholar
  26. 26.
    Kleemann R, Kapurniotu A, Frank RW, Gessner A, Mischke R, Flieger O, Juttner S, Brunner H, Bernhagen J (1998) Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase. J Mol Biol 280:85–102PubMedGoogle Scholar
  27. 27.
    Bini L, Magi B, Marzocchi B, Arcuri F, Tripodi S, Cintorino M, Sanchez JC, Frutiger S, Hughes G, Pallini V, Hochstrasser DF, Tosi P (1997) Protein expression profiles in human breast ductal carcinoma and histologically normal tissue. Electrophoresis 18:2832–2841PubMedGoogle Scholar
  28. 28.
    Meyer-Siegler K, Hudson PB (1996) Enhanced expression of macrophage migration inhibitory factor in prostatic adenocarcinoma metastases. Urology 48:448–452PubMedGoogle Scholar
  29. 29.
    del Vecchio MT, Tripodi SA, Arcuri F, Pergola L, Hako L, Vatti R, Cintorino M (2000) Macrophage migration inhibitory factor in prostatic adenocarcinoma: correlation with tumor grading and combination endocrine treatment-related changes. Prostate 45:51–57PubMedGoogle Scholar
  30. 30.
    Chesney J, Metz C, Bacher M, Peng T, Meinhardt A, Bucala R (1999) An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol Med 5:181–191PubMedGoogle Scholar
  31. 31.
    White ES, Flaherty KR, Carskadon S, Brant A, Iannettoni MD, Yee J, Orringer MB, Arenberg DA (2003) Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis. Clin Cancer Res 9:853–860PubMedGoogle Scholar
  32. 32.
    Shimizu T, Abe R, Nakamura H, Ohkawara A, Suzuki M, Nishihira J (1999) High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis. Biochem Biophys Res Commun 264:751–758PubMedGoogle Scholar
  33. 33.
    Nishihira J (1998) Novel pathophysiological aspects of macrophage migration inhibitory factor (review). Int J Mol Med 2:17–28PubMedGoogle Scholar
  34. 34.
    Baugh JA, Bucala R (2002) Macrophage migration inhibitory factor. Crit Care Med 30:S27–S35Google Scholar
  35. 35.
    Lue H, Kleemann R, Calandra T, Roger T, Bernhagen J (2002) Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes Infect 4:449–460PubMedGoogle Scholar
  36. 36.
    Mitchell RA (2004) Mechanisms and effectors of MIF-dependent promotion of tumourigenesis. Cell Signal 16:13–19PubMedGoogle Scholar
  37. 37.
    Bacher M, Metz CN, Calandra T, Mayer K, Chesney J, Lohoff M, Gemsa D, Donnelly T, Bucala R (1996) An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA 93:7849–7854PubMedGoogle Scholar
  38. 38.
    Calandra T, Spiegel LA, Metz CN, Bucala R (1998) Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria. Proc Natl Acad Sci USA 95:11383–11388PubMedGoogle Scholar
  39. 39.
    Abe R, Peng T, Sailors J, Bucala R, Metz CN (2001) Regulation of the CTL response by macrophage migration inhibitory factor. J Immunol 166:747–753PubMedGoogle Scholar
  40. 40.
    Yan X, Orentas RJ, Johnson BD (2006) Tumor-derived macrophage migration inhibitory factor (MIF) inhibits T lymphocyte activation. Cytokine 33:188–198PubMedGoogle Scholar
  41. 41.
    Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W, Manogue KR, Cerami A, Bucala R (1993) MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365:756–759PubMedGoogle Scholar
  42. 42.
    Bacher M, Meinhardt A, Lan HY, Mu W, Metz CN, Chesney JA, Calandra T, Gemsa D, Donnelly T, Atkins RC, Bucala R (1997) Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol 150:235–246PubMedGoogle Scholar
  43. 43.
    Calandra T, Echtenacher B, Roy DL, Pugin J, Metz CN, Hultner L, Heumann D, Mannel D, Bucala R, Glauser MP (2000) Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 6:164–170PubMedGoogle Scholar
  44. 44.
    Lind M, Trindade MC, Nakashima Y, Schurman DJ, Goodman SB, Smith L (1999) Chemotaxis and activation of particle-challenged human monocytes in response to monocyte migration inhibitory factor and C-C chemokines. J Biomed Mater Res 48:246–250PubMedGoogle Scholar
  45. 45.
    Hermanowski-Vosatka A, Mundt SS, Ayala JM, Goyal S, Hanlon WA, Czerwinski RM, Wright SD, Whitman CP (1999) Enzymatically inactive macrophage migration inhibitory factor inhibits monocyte chemotaxis and random migration. Biochemistry 38:12841–12849PubMedGoogle Scholar
  46. 46.
    Gregory JL, Morand EF, McKeown SJ, Ralph JA, Hall P, Yang YH, McColl SR, Hickey MJ (2006) Macrophage migration inhibitory factor induces macrophage recruitment via CC chemokine ligand 2. J Immunol 177:8072–8079PubMedGoogle Scholar
  47. 47.
    Calandra T, Bernhagen J, Mitchell RA, Bucala R (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179:1895–1902PubMedGoogle Scholar
  48. 48.
    Roger T, David J, Glauser MP, Calandra T (2001) MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414:920–924PubMedGoogle Scholar
  49. 49.
    Onodera S, Suzuki K, Matsuno T, Kaneda K, Takagi M, Nishihira J (1997) Macrophage migration inhibitory factor induces phagocytosis of foreign particles by macrophages in autocrine and paracrine fashion. Immunology 92:131–137PubMedGoogle Scholar
  50. 50.
    Juttner S, Bernhagen J, Metz CN, Rollinghoff M, Bucala R, Gessner A (1998) Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha. J Immunol 161:2383–2390PubMedGoogle Scholar
  51. 51.
    Pozzi LA, Weiser WY (1992) Human recombinant migration inhibitory factor activates human macrophages to kill tumor cells. Cell Immunol 145:372–379PubMedGoogle Scholar
  52. 52.
    Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, Cerami A, Bucala R (1995) MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377:68–71PubMedGoogle Scholar
  53. 53.
    Daun JM, Cannon JG (2000) Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IkappaBalpha. Am J Physiol Regul Integr Comp Physiol 279:R1043–R1049PubMedGoogle Scholar
  54. 54.
    Apte RS, Sinha D, Mayhew E, Wistow GJ, Niederkorn JY (1998) Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. J Immunol 160:5693–5696PubMedGoogle Scholar
  55. 55.
    Repp AC, Mayhew ES, Apte S, Niederkorn JY (2000) Human uveal melanoma cells produce macrophage migration-inhibitory factor to prevent lysis by NK cells. J Immunol 165:710–715PubMedGoogle Scholar
  56. 56.
    Arcuri F, Cintorino M, Carducci A, Papa S, Riparbelli MG, Mangioni S, Di Blasio AM, Tosi P, Vigano P (2006) Human decidual natural killer cells as a source and target of macrophage migration inhibitory factor. Reproduction 131:175–182PubMedGoogle Scholar
  57. 57.
    Esumi N, Budarf M, Ciccarelli L, Sellinger B, Kozak CA, Wistow G (1998) Conserved gene structure and genomic linkage for d-dopachrome tautomerase (DDT) and MIF. Mamm Genome 9:753–757PubMedGoogle Scholar
  58. 58.
    Rosengren E, Bucala R, Aman P, Jacobsson L, Odh G, Metz CN, Rorsman H (1996) The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Mol Med 2:143–149PubMedGoogle Scholar
  59. 59.
    Rosengren E, Aman P, Thelin S, Hansson C, Ahlfors S, Bjork P, Jacobsson L, Rorsman H (1997) The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase. FEBS Lett 417:85–88PubMedGoogle Scholar
  60. 60.
    Matsunaga J, Sinha D, Pannell L, Santis C, Solano F, Wistow GJ, Hearing VJ (1999) Enzyme activity of macrophage migration inhibitory factor toward oxidized catecholamines. J Biol Chem 274:3268–3271PubMedGoogle Scholar
  61. 61.
    Bendrat K, Al-Abed Y, Callaway DJ, Peng T, Calandra T, Metz CN, Bucala R (1997) Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor. Biochemistry 36:15356–15362PubMedGoogle Scholar
  62. 62.
    Mischke R, Gessner A, Kapurniotu A, Juttner S, Kleemann R, Brunner H, Bernhagen J (1997) Structure activity studies of the cytokine macrophage migration inhibitory factor (MIF) reveal a critical role for its carboxy terminus. FEBS Lett 414:226–232PubMedGoogle Scholar
  63. 63.
    Wen Y, Li GW, Bekhor I (1996) Lens epithelial cell mRNA. III. Elevated expression of macrophage migration inhibitory factor mRNA in galactose cataracts. Curr Eye Res 15:125–130PubMedGoogle Scholar
  64. 64.
    Mitchell RA, Metz CN, Peng T, Bucala R (1999) Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action. J Biol Chem 274:18100–18106PubMedGoogle Scholar
  65. 65.
    Kleemann R, Hausser A, Geiger G, Mischke R, Burger-Kentischer A, Flieger O, Johannes FJ, Roger T, Calandra T, Kapurniotu A, Grell M, Finkelmeier D, Brunner H, Bernhagen J (2000) Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 408:211–216PubMedGoogle Scholar
  66. 66.
    Takahashi N, Nishihira J, Sato Y, Kondo M, Ogawa H, Ohshima T, Une Y, Todo S (1998) Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth. Mol Med 4:707–714PubMedGoogle Scholar
  67. 67.
    Ren Y, Chan HM, Fan J, Xie Y, Chen YX, Li W, Jiang GP, Liu Q, Meinhardt A, Tam PK (2006) Inhibition of tumor growth and metastasis in vitro and in vivo by targeting macrophage migration inhibitory factor in human neuroblastoma. Oncogene 25:3501–3508PubMedGoogle Scholar
  68. 68.
    Ogawa H, Nishihira J, Sato Y, Kondo M, Takahashi N, Oshima T, Todo S (2000) An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis. Cytokine 12:309–314PubMedGoogle Scholar
  69. 69.
    Ren Y, Tsui HT, Poon RT, Ng IO, Li Z, Chen Y, Jiang G, Lau C, Yu WC, Bacher M, Fan ST (2003) Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma. Int J Cancer 107:22–29PubMedGoogle Scholar
  70. 70.
    Hira E, Ono T, Dhar DK, El-Assal ON, Hishikawa Y, Yamanoi A, Nagasue N (2005) Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma. Cancer 103:588–598PubMedGoogle Scholar
  71. 71.
    Shun CT, Lin JT, Huang SP, Lin MT, Wu MS (2005) Expression of macrophage migration inhibitory factor is associated with enhanced angiogenesis and advanced stage in gastric carcinomas. World J Gastroenterol 11:3767–3771PubMedGoogle Scholar
  72. 72.
    Ren Y, Law S, Huang X, Lee PY, Bacher M, Srivastava G, Wong J (2005) Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma. Ann Surg 242:55–63PubMedGoogle Scholar
  73. 73.
    Yang Y, Degranpre P, Kharfi A, Akoum A (2000) Identification of macrophage migration inhibitory factor as a potent endothelial cell growth-promoting agent released by ectopic human endometrial cells. J Clin Endocrinol Metab 85:4721–4727PubMedGoogle Scholar
  74. 74.
    Lue H, Kapurniotu A, Fingerle-Rowson G, Roger T, Leng L, Thiele M, Calandra T, Bucala R, Bernhagen J (2006) Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity. Cell Signal 18:688–703PubMedGoogle Scholar
  75. 75.
    Aeberli D, Yang Y, Mansell A, Santos L, Leech M, Morand EF (2006) Endogenous macrophage migration inhibitory factor modulates glucocorticoid sensitivity in macrophages via effects on MAP kinase phosphatase-1 and p38 MAP kinase. FEBS Lett 580:974–981PubMedGoogle Scholar
  76. 76.
    Amin MA, Haas CS, Zhu K, Mansfield PJ, Kim MJ, Lackowski NP, Koch AE (2006) Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3 kinase, and NFkappaB. Blood 107:2252–2261PubMedGoogle Scholar
  77. 77.
    Lacey D, Sampey A, Mitchell R, Bucala R, Santos L, Leech M, Morand E (2003) Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor. Arthritis Rheum 48:103–109PubMedGoogle Scholar
  78. 78.
    Hudson JD, Shoaibi MA, Maestro R, Carnero A, Hannon GJ, Beach DH (1999) A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med 190:1375–1382PubMedGoogle Scholar
  79. 79.
    Mitchell RA, Liao H, Chesney J, Fingerle-Rowson G, Baugh J, David J, Bucala R (2002) Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci USA 99:345–350PubMedGoogle Scholar
  80. 80.
    Petrenko O, Fingerle-Rowson G, Peng T, Mitchell RA, Metz CN (2003) Macrophage migration inhibitory factor deficiency is associated with altered cell growth and reduced susceptibility to Ras-mediated transformation. J Biol Chem 278:11078–11085PubMedGoogle Scholar
  81. 81.
    Petrenko O, Moll UM (2005) Macrophage migration inhibitory factor MIF interferes with the Rb-E2F pathway. Mol Cell 17:225–236PubMedGoogle Scholar
  82. 82.
    Claret FX, Hibi M, Dhut S, Toda T, Karin M (1996) A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature 383:453–457PubMedGoogle Scholar
  83. 83.
    Deng XW, Dubiel W, Wei N, Hofmann K, Mundt K, Colicelli J, Kato J, Naumann M, Segal D, Seeger M, Carr A, Glickman M, Chamovitz DA (2000) Unified nomenclature for the COP9 signalosome and its subunits: an essential regulator of development. Trends Genet 16:202–203PubMedGoogle Scholar
  84. 84.
    Shaulian E, Karin M (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol 4:E131–E136PubMedGoogle Scholar
  85. 85.
    Tomoda K, Kubota Y, Kato J (1999) Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature 398:160–165PubMedGoogle Scholar
  86. 86.
    Suzuki H, Kanagawa H, Nishihira J (1996) Evidence for the presence of macrophage migration inhibitory factor in murine reproductive organs and early embryos. Immunol Lett 51:141–147PubMedGoogle Scholar
  87. 87.
    Wada S, Fujimoto S, Mizue Y, Nishihira J (1997) Macrophage migration inhibitory factor in the human ovary: presence in the follicular fluids and production by granulosa cells. Biochem Mol Biol Int 41:805–814PubMedGoogle Scholar
  88. 88.
    Matsuura T, Sugimura M, Iwaki T, Ohashi R, Kanayama N, Nishihira J (2002) Anti-macrophage inhibitory factor antibody inhibits PMSG-hCG-induced follicular growth and ovulation in mice. J Assist Reprod Genet 19:591–595PubMedGoogle Scholar
  89. 89.
    Bove SE, Petroff MG, Nishibori M, Pate JL (2000) Macrophage migration inhibitory factor in the bovine corpus luteum: characterization of steady-state messenger ribonucleic acid and immunohistochemical localization. Biol Reprod 62:879–885PubMedGoogle Scholar
  90. 90.
    Arcuri F, Ricci C, Ietta F, Cintorino M, Tripodi SA, Cetin I, Garzia E, Schatz F, Klemi P, Santopietro R, Paulesu L (2001) Macrophage migration inhibitory factor in the human endometrium: expression and localization during the menstrual cycle and early pregnancy. Biol Reprod 64:1200–1205PubMedGoogle Scholar
  91. 91.
    Kats R, Al-Akoum M, Guay S, Metz C, Akoum A (2005) Cycle-dependent expression of macrophage migration inhibitory factor in the human endometrium. Hum Reprod 20:3518–3525PubMedGoogle Scholar
  92. 92.
    Paulesu L, Cateni C, Romagnoli R, Ietta F, Dantzer V (2005) Variation in macrophage-migration-inhibitory-factor immunoreactivity during porcine gestation. Biol Reprod 72:949–953PubMedGoogle Scholar
  93. 93.
    Wang B, Goff AK (2003) Interferon-tau stimulates secretion of macrophage migration inhibitory factor from bovine endometrial epithelial cells. Biol Reprod 69:1690–1696PubMedGoogle Scholar
  94. 94.
    Akoum A, Metz CN, Morin M (2005) Marked increase in macrophage migration inhibitory factor synthesis and secretion in human endometrial cells in response to human chorionic gonadotropin hormone. J Clin Endocrinol Metab 90:2904–2910PubMedGoogle Scholar
  95. 95.
    Cao WG, Morin M, Metz C, Maheux R, Akoum A (2005) Stimulation of macrophage migration inhibitory factor expression in endometrial stromal cells by interleukin 1, beta involving the nuclear transcription factor NFkappaB. Biol Reprod 73:565–570PubMedGoogle Scholar
  96. 96.
    Cao WG, Morin M, Sengers V, Metz C, Roger T, Maheux R, Akoum A (2006) Tumour necrosis factor-alpha up-regulates macrophage migration inhibitory factor expression in endometrial stromal cells via the nuclear transcription factor NF-kappaB. Hum Reprod 21:421–428PubMedGoogle Scholar
  97. 97.
    Schaefer TM, Fahey JV, Wright JA, Wira CR (2005) Migration inhibitory factor secretion by polarized uterine epithelial cells is enhanced in response to the TLR3 agonist poly (I:C). Am J Reprod Immunol 54:193–202PubMedGoogle Scholar
  98. 98.
    Arcuri F, Buchwalder L, Toti P, Cintorino M, Tosi P, Lockwood CJ, Rybalov B, Schatz F (2007) Differential regulation of colony stimulating factor 1 and macrophage migration inhibitory factor expression by inflammatory cytokines in term human decidua: implications for macrophage trafficking at the fetal-maternal interface. Biol Reprod 76:433–439PubMedGoogle Scholar
  99. 99.
    Lockwood CJ, Matta P, Krikun G, Koopman LA, Masch R, Toti P, Arcuri F, Huang ST, Funai EF, Schatz F (2006) Regulation of monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha and interleukin-1beta in first trimester human decidual cells: implications for preeclampsia. Am J Pathol 168:445–452PubMedGoogle Scholar
  100. 100.
    Lockwood CJ, Arcuri F, Toti P, Felice CD, Krikun G, Guller S, Buchwalder LF, Schatz F (2006) Tumor necrosis factor-alpha and interleukin-1beta regulate interleukin-8 expression in third trimester decidual cells: implications for the genesis of chorioamnionitis. Am J Pathol 169:1294–1302PubMedGoogle Scholar
  101. 101.
    Zeng FY, Weiser WY, Kratzin H, Stahl B, Karas M, Gabius HJ (1993) The major binding protein of the interferon antagonist sarcolectin in human placenta is a macrophage migration inhibitory factor. Arch Biochem Biophys 303:74–80PubMedGoogle Scholar
  102. 102.
    Arcuri F, Cintorino M, Vatti R, Carducci A, Liberatori S, Paulesu L (1999) Expression of macrophage migration inhibitory factor transcript and protein by first-trimester human trophoblasts. Biol Reprod 60:1299–1303PubMedGoogle Scholar
  103. 103.
    Ietta F, Todros T, Ticconi C, Piccoli E, Zicari A, Piccione E, Paulesu L (2002) Macrophage migration inhibitory factor in human pregnancy and labor. Am J Reprod Immunol 48:404–409PubMedGoogle Scholar
  104. 104.
    Chaiworapongsa T, Romero R, Espinoza J, Kim YM, Edwin S, Bujold E, Gomez R, Kuivaniemi H (2005) Macrophage migration inhibitory factor in patients with preterm parturition and microbial invasion of the amniotic cavity. J Matern Fetal Neonatal Med 18:405–416PubMedGoogle Scholar
  105. 105.
    Ietta F, Wu Y, Romagnoli R, Soleymanlou N, Orsini B, Zamudio S, Paulesu L, Caniggia I (2007) Oxygen regulation of macrophage migration inhibitory factor in human placenta. Am J Physiol Endocrinol Metab 292:E272–E280PubMedGoogle Scholar
  106. 106.
    Zicari A, Ticconi C, Ietta F, Belmonte A, Bechi N, Realacci M, Di Vito M, Arcuri F, Russo M, Piccione E, Paulesu L (2006) Macrophage migration inhibitory factor-nitric oxide interaction in human fetal membranes at term pregnancy. J Soc Gynecol Investig 13:263–270PubMedGoogle Scholar
  107. 107.
    Todros T, Bontempo S, Piccoli E, Ietta F, Romagnoli R, Biolcati M, Castellucci M, Paulesu L (2005) Increased levels of macrophage migration inhibitory factor (MIF) in preeclampsia. Eur J Obstet Gynecol Reprod Biol 123:162–166PubMedGoogle Scholar
  108. 108.
    Yamada H, Kato EH, Morikawa M, Shimada S, Saito H, Watari M, Minakami H, Nishihira J (2003) Decreased serum levels of macrophage migration inhibition factor in miscarriages with normal chromosome karyotype. Hum Reprod 18:616–620PubMedGoogle Scholar
  109. 109.
    Hristoskova S, Holzgreve W, Zhong XY, Hahn S (2006) Macrophage migration inhibition factor is elevated in pregnancy, but not to a greater extent in preeclampsia. Arch Gynecol Obstet 274:25–28PubMedGoogle Scholar
  110. 110.
    Kats R, Metz CN, Akoum A (2002) Macrophage migration inhibitory factor is markedly expressed in active and early-stage endometriotic lesions. J Clin Endocrinol Metab 87:883–889PubMedGoogle Scholar
  111. 111.
    Kats R, Collette T, Metz CN, Akoum A (2002) Marked elevation of macrophage migration inhibitory factor in the peritoneal fluid of women with endometriosis. Fertil Steril 78:69–76PubMedGoogle Scholar
  112. 112.
    Morin M, Bellehumeur C, Therriault MJ, Metz C, Maheux R, Akoum A (2005) Elevated levels of macrophage migration inhibitory factor in the peripheral blood of women with endometriosis. Fertil Steril 83:865–872PubMedGoogle Scholar
  113. 113.
    Mahutte NG, Matalliotakis IM, Goumenou AG, Koumantakis GE, Vassiliadis S, Arici A (2004) Elevations in peritoneal fluid macrophage migration inhibitory factor are independent of the depth of invasion or stage of endometriosis. Fertil Steril 82:97–101PubMedGoogle Scholar
  114. 114.
    Akoum A, Metz CN, Al-Akoum M, Kats R (2006) Macrophage migration inhibitory factor expression in the intrauterine endometrium of women with endometriosis varies with disease stage, infertility status, and pelvic pain. Fertil Steril 85:1379–1385PubMedGoogle Scholar
  115. 115.
    Redman CW, Sacks GP, Sargent IL (1999) Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 180:499–506PubMedGoogle Scholar
  116. 116.
    Moffett-King A (2002) Natural killer cells and pregnancy. Nat Rev Immunol 2:656–663PubMedGoogle Scholar
  117. 117.
    Kudo Y, Boyd CA, Spyropoulou I, Redman CW, Takikawa O, Katsuki T, Hara T, Ohama K, Sargent IL (2004) Indoleamine 2,3-dioxygenase: distribution and function in the developing human placenta. J Reprod Immunol 61:87–98PubMedGoogle Scholar
  118. 118.
    Girardi G, Bulla R, Salmon JE, Tedesco F (2006) The complement system in the pathophysiology of pregnancy. Mol Immunol 43:68–77PubMedGoogle Scholar
  119. 119.
    Trundley A, Moffett A (2004) Human uterine leukocytes and pregnancy. Tissue Antigens 63:1–12PubMedGoogle Scholar
  120. 120.
    Dosiou C, Giudice LC (2005) Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives. Endocr Rev 26:44–62PubMedGoogle Scholar
  121. 121.
    Saito S, Morii T, Enomoto M, Sakakura S, Nishikawa K, Narita N, Ichijo M (1993) The effect of interleukin 2 and transforming growth factor-beta 2 (TGF-beta 2) on the proliferation and natural killer activity of decidual CD16- CD56bright natural killer cells. Cell Immunol 152:605–613PubMedGoogle Scholar
  122. 122.
    Verma S, Hiby SE, Loke YW, King A (2000) Human decidual natural killer cells express the receptor for and respond to the cytokine interleukin 15. Biol Reprod 62:959–968PubMedGoogle Scholar
  123. 123.
    Guimond MJ, Luross JA, Wang B, Terhorst C, Danial S, Croy BA (1997) Absence of natural killer cells during murine pregnancy is associated with reproductive compromise in TgE26 mice. Biol Reprod 56:169–179PubMedGoogle Scholar
  124. 124.
    Guimond MJ, Wang B, Croy BA (1998) Engraftment of bone marrow from severe combined immunodeficient (SCID) mice reverses the reproductive deficits in natural killer cell-deficient tg epsilon 26 mice. J Exp Med 187:217–223PubMedGoogle Scholar
  125. 125.
    Bulmer JN, Morrison L, Longfellow M, Ritson A, Pace D (1991) Granulated lymphocytes in human endometrium: histochemical and immunohistochemical studies. Hum Reprod 6:791–798PubMedGoogle Scholar
  126. 126.
    Avril T, Jarousseau AC, Watier H, Boucraut J, Le Bouteiller P, Bardos P, Thibault G (1999) Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism. J Immunol 162:5902–5909PubMedGoogle Scholar
  127. 127.
    Saito S, Umekage H, Nishikawa K, Morii T, Narita N, Enomoto M, Sakakura S, Harada N, Ichijo M, Morikawa H (1996) Interleukin 4 (IL-4) blocks the IL-2-induced increased in natural killer activity and DNA synthesis of decidual CD16-CD56bright NK cells by inhibiting expression of the IL-2 receptor alpha, beta, and gamma. Cell Immunol 170:71–77PubMedGoogle Scholar
  128. 128.
    McIntire RH, Hunt JS (2005) Antigen presenting cells and HLA-G-a review. Placenta 26 Suppl A:S104–S109PubMedGoogle Scholar
  129. 129.
    Mosser DM (2003) The many faces of macrophage activation. J Leukoc Biol 73:209–212PubMedGoogle Scholar
  130. 130.
    Duffield JS (2003) The inflammatory macrophage: a story of Jekyll and Hyde. Clin Sci (Lond) 104:27–38CrossRefGoogle Scholar
  131. 131.
    Starkey PM, Sargent IL, Redman CW (1988) Cell populations in human early pregnancy decidua: characterization and isolation of large granular lymphocytes by flow cytometry. Immunology 65:129–134PubMedGoogle Scholar
  132. 132.
    Mor G, Abrahams VM (2003) Potential role of macrophages as immunoregulators of pregnancy. Reprod Biol Endocrinol 1:119PubMedGoogle Scholar
  133. 133.
    Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3:23–35PubMedGoogle Scholar
  134. 134.
    Heikkinen J, Mottonen M, Komi J, Alanen A, Lassila O (2003) Phenotypic characterization of human decidual macrophages. Clin Exp Immunol 131:498–505PubMedGoogle Scholar
  135. 135.
    Jones RL, Stoikos C, Findlay JK, Salamonsen LA (2006) TGF-beta superfamily expression and actions in the endometrium and placenta. Reproduction 132:217–232PubMedGoogle Scholar
  136. 136.
    Reister F, Frank HG, Kingdom JC, Heyl W, Kaufmann P, Rath W, Huppertz B (2001) Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab Invest 81:1143–1152PubMedGoogle Scholar
  137. 137.
    Bowen JM, Chamley L, Mitchell MD, Keelan JA (2002) Cytokines of the placenta and extra-placental membranes: biosynthesis, secretion and roles in establishment of pregnancy in women. Placenta 23:239–256PubMedGoogle Scholar
  138. 138.
    Medawar PB (1953) Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp Soc Exp Biol 7:320–338Google Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Paola Viganò
    • 1
  • Marcella Cintorino
    • 2
  • Frederick Schatz
    • 3
  • Charles J. Lockwood
    • 3
  • Felice Arcuri
    • 2
  1. 1.II Department of Obstetrics and GynecologyUniversity of Milan and Istituto Auxologico ItalianoMilanItaly
  2. 2.Department of Human Pathology and Oncology, Section of PathologyUniversity of Siena—School of MedicineSienaItaly
  3. 3.Department of Obstetrics, Gynecology and Reproductive SciencesYale University School of MedicineNew HavenUSA

Personalised recommendations